Winkelmann, J., D. Czamara, B. Schormair, F. Knauf, E. C. Schulte, C. Trenkwalder, Y. Dauvilliers, O. Polo, B. Högl, K. Berger, A. Fuhs, N. Gross, K. Stiasny-Kolster, W. Oertel, C. G. Bachmann, W. Paulus, L. Xiong, J. Montplaisir, G. A. Rouleau, I. Fietze, J. Vavrova, D. Kemlink, K. Sonka, S. Nevsimalova, S. C. Lin, Z. Wszolek, C. Vilarino-Guell, M. J. Farrer, V. Gschliesser, B. Frauscher, T. Falkenstetter, W. Poewe, R. P. Allen, C. J. Earley, W. G. Ondo, W. D. Le, D. Spieler, M. Kaffe, A. Zimprich, J. Kettunen, M. Perola, K. Silander, I. Cournu-Rebeix, M. Francavilla, C. Fontenille, B. Fontaine, P. Vodicka, H. Prokisch, P. Lichtner, P. Peppard, J. Faraco, E. Mignot, C. Gieger, T. Illig, H. E. Wichmann, B. Müller-Myhsok and T. Meitinger: Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1. In: PLoS Genetics 7, 7, Seq. No.: e1002171 (2011).
Schormair, B., D. Kemlink, D. Roeske, G. Eckstein, L. Xiong, P. Lichtner, S. Ripke, C. Trenkwalder, A. Zimprich, K. Stiasny-Kolster, W. Oertel, C. G. Bachmann, W. Paulus, B. Högl, B. Frauscher, V. Gschliesser, W. Poewe, I. Peglau, P. Vodicka, J. Vavrova, K. Sonka, S. Nevsimalova, J. Montplaisir, G. Turecki, G. Rouleau, C. Gieger, T. Illig, H. E. Wichmann, F. Holsboer, B. Mueller-Myhsok, T. Meitinger and J. Winkelmann: PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. In: Nature Genetics 40, 8, 946-948 (2008).
Winkelmann, J., B. Schormair, P. Lichtner, S. Ripke, L. Xiong, S. Jalilzadeh, S. Fulda, B. Pütz, G. Eckstein, S. Hauk, C. Trenkwalder, A. Zimprich, K. Stiasny-Kolster, W. Oertel, C. G. Bachmann, W. Paulus, I. Peglau, I. Eisensehr, J. Montplaisir, G. Turecki, G. Rouleau, C. Gieger, T. Illig, E. Wichmann, F. Holsboer, B. Müller-Myhsok and T. Meitinger: Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. In: Nature Genetics 39, 8, 1000-1006 (2007).
Bachmann, C. G., A. Bilang-Bleuel, S. De Carli, A. C. E. Linthorst and J. M. H. M. Reul: The selective glucocorticoid receptor antagonist ORG 34116 decreases immobility time in the forced swim test and affects cAMP-responsive element-binding protein phosphorylation in rat brain. In: Neuroendocrinology 81, 2, 129-136 (2005).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.